nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—CA6—saliva—conduct disorder	0.0959	0.311	CbGeAlD
Topiramate—GRIA4—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0277	0.04	CbGpPWpGaD
Topiramate—GRIK4—brain—conduct disorder	0.0276	0.0895	CbGeAlD
Topiramate—GABRB2—GABA A receptor activation—GABRA2—conduct disorder	0.0218	0.0315	CbGpPWpGaD
Topiramate—GRIA4—brain—conduct disorder	0.0218	0.0707	CbGeAlD
Topiramate—GRIA3—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0201	0.0291	CbGpPWpGaD
Topiramate—GRIK3—brain—conduct disorder	0.0201	0.0653	CbGeAlD
Topiramate—GRIK5—brain—conduct disorder	0.0201	0.0653	CbGeAlD
Topiramate—GABRG2—GABA A receptor activation—GABRA2—conduct disorder	0.0199	0.0288	CbGpPWpGaD
Topiramate—GRIK1—brain—conduct disorder	0.0191	0.062	CbGeAlD
Topiramate—GRIK4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.018	0.026	CbGpPWpGaD
Topiramate—GRIK5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.018	0.026	CbGpPWpGaD
Topiramate—GRIA3—brain—conduct disorder	0.0178	0.0577	CbGeAlD
Topiramate—GABRA1—GABA A receptor activation—GABRA2—conduct disorder	0.0174	0.0252	CbGpPWpGaD
Topiramate—GRIK1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0168	0.0242	CbGpPWpGaD
Topiramate—GRIK3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0168	0.0242	CbGpPWpGaD
Topiramate—GRIA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0142	0.0206	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0135	0.0196	CbGpPWpGaD
Topiramate—GRIK4—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0135	0.0196	CbGpPWpGaD
Topiramate—GABRB2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0134	0.0193	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0126	0.0182	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0126	0.0182	CbGpPWpGaD
Topiramate—GABRG2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0122	0.0176	CbGpPWpGaD
Topiramate—GRIA1—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0121	0.0174	CbGpPWpGaD
Topiramate—GRIA4—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.0107	0.0155	CbGpPWpGaD
Topiramate—GABRA1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0107	0.0154	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—GABRA2—conduct disorder	0.0104	0.015	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—GABRA2—conduct disorder	0.0104	0.015	CbGpPWpGaD
Topiramate—GRIA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0103	0.015	CbGpPWpGaD
Topiramate—CA7—brain—conduct disorder	0.00979	0.0318	CbGeAlD
Topiramate—GRIK1—Neuronal System—GABRA2—conduct disorder	0.00965	0.0139	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—GABRA2—conduct disorder	0.00965	0.0139	CbGpPWpGaD
Topiramate—GRIA1—brain—conduct disorder	0.00948	0.0308	CbGeAlD
Topiramate—CA9—Regulation of gene expression by Hypoxia-inducible Factor—EP300—conduct disorder	0.00886	0.0128	CbGpPWpGaD
Topiramate—GRIA2—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.00843	0.0122	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—GABRA2—conduct disorder	0.0082	0.0119	CbGpPWpGaD
Topiramate—GRIA3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00778	0.0112	CbGpPWpGaD
Topiramate—GRIA2—brain—conduct disorder	0.00753	0.0245	CbGeAlD
Topiramate—GABRB2—GABA receptor activation—GABRA2—conduct disorder	0.00708	0.0102	CbGpPWpGaD
Topiramate—SCN1A—brain—conduct disorder	0.00687	0.0223	CbGeAlD
Topiramate—GRIK2—brain—conduct disorder	0.00681	0.0221	CbGeAlD
Topiramate—GRIK4—Transmission across Chemical Synapses—COMT—conduct disorder	0.00652	0.00942	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—COMT—conduct disorder	0.00652	0.00942	CbGpPWpGaD
Topiramate—GABRG2—GABA receptor activation—GABRA2—conduct disorder	0.00648	0.00936	CbGpPWpGaD
Topiramate—GRIK4—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00647	0.00936	CbGpPWpGaD
Topiramate—GRIK5—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00647	0.00936	CbGpPWpGaD
Topiramate—CA12—brain—conduct disorder	0.00636	0.0206	CbGeAlD
Topiramate—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0062	0.00896	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00606	0.00876	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00606	0.00876	CbGpPWpGaD
Topiramate—GRIK3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00602	0.0087	CbGpPWpGaD
Topiramate—GRIK1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00602	0.0087	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—GABRA2—conduct disorder	0.00596	0.00861	CbGpPWpGaD
Topiramate—CA5B—brain—conduct disorder	0.00571	0.0185	CbGeAlD
Topiramate—GRIK2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00567	0.00819	CbGpPWpGaD
Topiramate—GABRA1—GABA receptor activation—GABRA2—conduct disorder	0.00566	0.00818	CbGpPWpGaD
Topiramate—SCN5A—brain—conduct disorder	0.00553	0.0179	CbGeAlD
Topiramate—GABRB2—brain—conduct disorder	0.00536	0.0174	CbGeAlD
Topiramate—GABRG2—brain—conduct disorder	0.00536	0.0174	CbGeAlD
Topiramate—GRIA4—Transmission across Chemical Synapses—COMT—conduct disorder	0.00515	0.00745	CbGpPWpGaD
Topiramate—GRIA4—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00512	0.0074	CbGpPWpGaD
Topiramate—CA1—brain—conduct disorder	0.00504	0.0164	CbGeAlD
Topiramate—GRIK4—Neuronal System—COMT—conduct disorder	0.00499	0.00722	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—COMT—conduct disorder	0.00499	0.00722	CbGpPWpGaD
Topiramate—GRIK5—Neuronal System—MAOA—conduct disorder	0.00496	0.00717	CbGpPWpGaD
Topiramate—GRIK4—Neuronal System—MAOA—conduct disorder	0.00496	0.00717	CbGpPWpGaD
Topiramate—GABRA1—brain—conduct disorder	0.00473	0.0154	CbGeAlD
Topiramate—GRIA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00466	0.00674	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—COMT—conduct disorder	0.00464	0.00671	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—COMT—conduct disorder	0.00464	0.00671	CbGpPWpGaD
Topiramate—GRIK1—Neuronal System—MAOA—conduct disorder	0.00461	0.00666	CbGpPWpGaD
Topiramate—GRIK3—Neuronal System—MAOA—conduct disorder	0.00461	0.00666	CbGpPWpGaD
Topiramate—GRIA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00434	0.00627	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00426	0.00616	CbGpPWpGaD
Topiramate—GABRB2—Orphan transporters—GABRA2—conduct disorder	0.00413	0.00597	CbGpPWpGaD
Topiramate—GRIA4—Neuronal System—COMT—conduct disorder	0.00395	0.00571	CbGpPWpGaD
Topiramate—CA4—brain—conduct disorder	0.00394	0.0128	CbGeAlD
Topiramate—GRIA4—Neuronal System—MAOA—conduct disorder	0.00392	0.00567	CbGpPWpGaD
Topiramate—CA9—Cellular response to hypoxia—EP300—conduct disorder	0.00391	0.00566	CbGpPWpGaD
Topiramate—GABRG2—Orphan transporters—GABRA2—conduct disorder	0.00378	0.00546	CbGpPWpGaD
Topiramate—GRIA3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00374	0.00541	CbGpPWpGaD
Topiramate—GRIA3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00372	0.00537	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—GABRA2—conduct disorder	0.00357	0.00516	CbGpPWpGaD
Topiramate—GABRA1—Orphan transporters—GABRA2—conduct disorder	0.0033	0.00477	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—GABRA2—conduct disorder	0.00327	0.00472	CbGpPWpGaD
Topiramate—CA2—brain—conduct disorder	0.00327	0.0106	CbGeAlD
Topiramate—GRIA2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00326	0.00471	CbGpPWpGaD
Topiramate—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00326	0.00471	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00298	0.0043	CbGpPWpGaD
Topiramate—GABRB2—Ion channel transport—GABRA2—conduct disorder	0.0029	0.00419	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—COMT—conduct disorder	0.00287	0.00415	CbGpPWpGaD
Topiramate—GRIA3—Neuronal System—MAOA—conduct disorder	0.00285	0.00412	CbGpPWpGaD
Topiramate—GABRG2—Ion channel transport—GABRA2—conduct disorder	0.00265	0.00383	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0026	0.00376	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—GABRA2—conduct disorder	0.0025	0.00361	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00245	0.00354	CbGpPWpGaD
Topiramate—GABRA1—Ion channel transport—GABRA2—conduct disorder	0.00232	0.00335	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.0023	0.00333	CbGpPWpGaD
Topiramate—CYP2C19—Melatonin metabolism and effects—MAOA—conduct disorder	0.00225	0.00326	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00224	0.00324	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00224	0.00324	CbGpPWpGaD
Topiramate—GRIA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00223	0.00322	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00205	0.00296	CbGpPWpGaD
Topiramate—GRIK2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00204	0.00294	CbGpPWpGaD
Topiramate—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.002	0.00289	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00196	0.00283	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—GABRA2—conduct disorder	0.00188	0.00271	CbGpPWpGaD
Topiramate—CA9—HIF-1-alpha transcription factor network—EP300—conduct disorder	0.0018	0.0026	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00173	0.0025	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—COMT—conduct disorder	0.00172	0.00248	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—GABRA2—conduct disorder	0.00172	0.00248	CbGpPWpGaD
Topiramate—GRIA1—Neuronal System—MAOA—conduct disorder	0.00171	0.00247	CbGpPWpGaD
Topiramate—CA1—C-MYB transcription factor network—EP300—conduct disorder	0.00169	0.00244	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—COMT—conduct disorder	0.00157	0.00227	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00157	0.00227	CbGpPWpGaD
Topiramate—GRIK2—Neuronal System—MAOA—conduct disorder	0.00156	0.00226	CbGpPWpGaD
Topiramate—GRIA2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00156	0.00225	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—SLC6A4—conduct disorder	0.00152	0.00219	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—GABRA2—conduct disorder	0.0015	0.00217	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00141	0.00204	CbGpPWpGaD
Topiramate—CA5A—Metabolism—CGA—conduct disorder	0.00133	0.00192	CbGpPWpGaD
Topiramate—CA6—Metabolism—CGA—conduct disorder	0.00133	0.00192	CbGpPWpGaD
Topiramate—CA7—Metabolism—CGA—conduct disorder	0.00124	0.00179	CbGpPWpGaD
Topiramate—CA5B—Metabolism—CGA—conduct disorder	0.00124	0.00179	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—COMT—conduct disorder	0.0012	0.00174	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—MAOA—conduct disorder	0.00119	0.00172	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00118	0.0017	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00117	0.00169	CbGpPWpGaD
Topiramate—CA12—Metabolism—CGA—conduct disorder	0.00115	0.00166	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.00114	0.00165	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00108	0.00156	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00107	0.00155	CbGpPWpGaD
Topiramate—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00102	0.00148	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00101	0.00146	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—COMT—conduct disorder	0.000942	0.00136	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.000935	0.00135	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00093	0.00134	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000922	0.00133	CbGpPWpGaD
Topiramate—CA4—Metabolism—CGA—conduct disorder	0.000915	0.00132	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—COMT—conduct disorder	0.000903	0.0013	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—MAOA—conduct disorder	0.000896	0.0013	CbGpPWpGaD
Topiramate—CA2—Metabolism—CGA—conduct disorder	0.000877	0.00127	CbGpPWpGaD
Topiramate—CA1—Metabolism—CGA—conduct disorder	0.000841	0.00122	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—COMT—conduct disorder	0.000826	0.00119	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—MAOA—conduct disorder	0.00082	0.00118	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000806	0.00117	CbGpPWpGaD
Topiramate—SCN5A—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000748	0.00108	CbGpPWpGaD
Topiramate—CA9—Metabolism—CGA—conduct disorder	0.000739	0.00107	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—COMT—conduct disorder	0.000722	0.00104	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—MAOA—conduct disorder	0.000717	0.00104	CbGpPWpGaD
Topiramate—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000614	0.000887	CbGpPWpGaD
Topiramate—CA6—Metabolism—COMT—conduct disorder	0.000599	0.000865	CbGpPWpGaD
Topiramate—CA5A—Metabolism—COMT—conduct disorder	0.000599	0.000865	CbGpPWpGaD
Topiramate—CA5A—Metabolism—MAOA—conduct disorder	0.000594	0.000859	CbGpPWpGaD
Topiramate—CA6—Metabolism—MAOA—conduct disorder	0.000594	0.000859	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—EP300—conduct disorder	0.000594	0.000858	CbGpPWpGaD
Topiramate—CA5B—Metabolism—COMT—conduct disorder	0.000559	0.000808	CbGpPWpGaD
Topiramate—CA7—Metabolism—COMT—conduct disorder	0.000559	0.000808	CbGpPWpGaD
Topiramate—CA5B—Metabolism—MAOA—conduct disorder	0.000555	0.000802	CbGpPWpGaD
Topiramate—CA7—Metabolism—MAOA—conduct disorder	0.000555	0.000802	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—COMT—conduct disorder	0.000546	0.000789	CbGpPWpGaD
Topiramate—CYP2C19—Biological oxidations—MAOA—conduct disorder	0.000542	0.000784	CbGpPWpGaD
Topiramate—CYP2C19—Metapathway biotransformation—COMT—conduct disorder	0.000539	0.000778	CbGpPWpGaD
Topiramate—CA12—Metabolism—COMT—conduct disorder	0.000518	0.000748	CbGpPWpGaD
Topiramate—CA12—Metabolism—MAOA—conduct disorder	0.000514	0.000743	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000493	0.000712	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.000465	0.000671	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—EP300—conduct disorder	0.000423	0.000611	CbGpPWpGaD
Topiramate—CA4—Metabolism—COMT—conduct disorder	0.000413	0.000597	CbGpPWpGaD
Topiramate—CA4—Metabolism—MAOA—conduct disorder	0.00041	0.000592	CbGpPWpGaD
Topiramate—CA2—Metabolism—COMT—conduct disorder	0.000396	0.000572	CbGpPWpGaD
Topiramate—CA2—Metabolism—MAOA—conduct disorder	0.000393	0.000568	CbGpPWpGaD
Topiramate—CA1—Metabolism—COMT—conduct disorder	0.000379	0.000548	CbGpPWpGaD
Topiramate—CA1—Metabolism—MAOA—conduct disorder	0.000377	0.000545	CbGpPWpGaD
Topiramate—CA9—Metabolism—COMT—conduct disorder	0.000334	0.000482	CbGpPWpGaD
Topiramate—CA9—Metabolism—MAOA—conduct disorder	0.000331	0.000479	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—COMT—conduct disorder	0.000328	0.000475	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—MAOA—conduct disorder	0.000326	0.000471	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	0.000324	0.000468	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—EP300—conduct disorder	0.000297	0.00043	CbGpPWpGaD
Topiramate—CA5A—Metabolism—EP300—conduct disorder	0.000257	0.000371	CbGpPWpGaD
Topiramate—CA6—Metabolism—EP300—conduct disorder	0.000257	0.000371	CbGpPWpGaD
Topiramate—CA7—Metabolism—EP300—conduct disorder	0.00024	0.000346	CbGpPWpGaD
Topiramate—CA5B—Metabolism—EP300—conduct disorder	0.00024	0.000346	CbGpPWpGaD
Topiramate—CA12—Metabolism—EP300—conduct disorder	0.000222	0.000321	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CGA—conduct disorder	0.000207	0.000299	CbGpPWpGaD
Topiramate—CA4—Metabolism—EP300—conduct disorder	0.000177	0.000256	CbGpPWpGaD
Topiramate—CA2—Metabolism—EP300—conduct disorder	0.00017	0.000245	CbGpPWpGaD
Topiramate—CA1—Metabolism—EP300—conduct disorder	0.000163	0.000235	CbGpPWpGaD
Topiramate—CA9—Metabolism—EP300—conduct disorder	0.000143	0.000207	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CGA—conduct disorder	0.000124	0.00018	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—COMT—conduct disorder	9.34e-05	0.000135	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MAOA—conduct disorder	9.27e-05	0.000134	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—EP300—conduct disorder	8.99e-05	0.00013	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—COMT—conduct disorder	5.62e-05	8.12e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MAOA—conduct disorder	5.58e-05	8.06e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—EP300—conduct disorder	4.01e-05	5.79e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—EP300—conduct disorder	2.41e-05	3.48e-05	CbGpPWpGaD
